Apr 6, 2018 8:30 am EDT EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
Mar 8, 2018 8:30 am EST EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Mar 2, 2018 4:28 pm EST EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
Feb 5, 2018 8:30 am EST EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
Dec 19, 2017 8:30 am EST EyeGate Awarded New U.S. Patent for Iontophoretic Delivery of Corticosteroids to the Eye
Dec 18, 2017 8:30 am EST EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment
Nov 14, 2017 8:00 am EST EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update